Egypt Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Date: May 1, 2011
Pages: 85
Price:
US$ 2,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EEABEF9B926EN
Leaflet:

Download PDF Leaflet

Egypt Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
Egypt Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

”Egypt Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Egypt Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope
  • Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
  • 2010 company shares and distribution shares data for each of the four market categories.
  • Global corporate-level profiles of key companies operating within the Egypt Drug Delivery Devicesmarket.
  • Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, B. Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc. and others.

Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Egypt Drug Delivery Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 DRUG DELIVERY DEVICES IN EGYPT

3.1 Drug Delivery Devices, Egypt, Overall Revenue ($m), 2003-2017
3.2 Drug Delivery Devices, Egypt, Category Volume (Units), 2003-2017
3.3 Drug Delivery Devices, Egypt, Company Share (2009-2010)

4 CENTRAL VENOUS CATHETERS IN EGYPT

4.1 Central Venous Catheters Overall Revenue (2003-2017)
4.2 Central Venous Catheters Overall Volume (2003-2017)
4.3 Central Venous Catheters Average Price (2003-2017)
4.4 Central Venous Catheters Distribution Share (2009-2010)
4.5 Central Venous Catheters, Egypt, Company Share (2009-2010)

5 INFUSION SYSTEMS IN EGYPT

5.1 Infusion Systems Overall Revenue (2003-2017)
  5.1.1 Syringe Pumps Revenue (2003-2017)
  5.1.2 Ambulatory Infusion Pumps Revenue (2003-2017)
5.2 Infusion Systems Overall Volume (2003-2017)
  5.2.1 Syringe Pumps Volume (2003-2017)
  5.2.2 Ambulatory Infusion Pumps Volume (2003-2017)
5.3 Infusion Systems Average Price (2003-2017)
5.4 Infusion Systems Distribution Share (2009-2010)
5.5 Infusion Systems, Egypt, Company Share (2009-2010)

6 METERED DOSE INHALER DEVICES IN EGYPT

6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017)
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017)
6.3 Metered Dose Inhaler Devices Average Price (2003-2017)
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010)
6.5 Metered Dose Inhaler Devices, Egypt, Company Share (2009-2010)

7 NEEDLE FREE INJECTIONS IN EGYPT

7.1 Needle Free Injections Overall Revenue (2003-2017)
7.2 Needle Free Injections Overall Volume (2003-2017)
7.3 Needle Free Injections Average Price (2003-2017)
7.4 Needle Free Injections Distribution Share (2009-2010)
7.5 Needle Free Injections, Egypt, Company Share (2009-2010)

8 OVERVIEW OF KEY COMPANIES IN EGYPT DRUG DELIVERY DEVICES MARKET

8.1 GlaxoSmithKline plc
  8.1.1 Company Overview
8.2 AstraZeneca PLC
  8.2.1 Company Overview
8.3 Boehringer Ingelheim GmbH
  8.3.1 Company Overview
8.4 B. Braun Melsungen AG
  8.4.1 Company Overview
8.5 Fresenius Kabi AG
  8.5.1 Company Overview
8.6 Hospira, Inc.
  8.6.1 Company Overview
8.7 Medtronic, Inc.
  8.7.1 Company Overview
8.8 Baxter International Inc.
  8.8.1 Company Overview
8.9 Smiths Medical
  8.9.1 Company Overview
8.10 Terumo Corporation
  8.10.1 Company Overview
8.11 3M Health Care
  8.11.1 Company Overview
8.12 CareFusion Corporation
  8.12.1 Company Overview
8.13 Teleflex Incorporated
  8.13.1 Company Overview
8.14 Arcomed A.G. Medical Systems
  8.14.1 Company Overview
8.15 Edwards Lifesciences Corporation
  8.15.1 Company Overview
8.16 JMS CO., LTD.
  8.16.1 Company Overview
8.17 Cook Medical Incorporated
  8.17.1 Company Overview
8.18 Consort Medical plc
  8.18.1 Company Overview
8.19 Becton, Dickinson and Company
  8.19.1 Company Overview
8.20 INJEX - Equidyne Systems
  8.20.1 Company Overview
8.21 Bioject Medical Technologies Inc.
  8.21.1 Company Overview

9 APPENDIX

9.1 Global Markets Direct Research Methodology
9.2 Definitions of Markets Covered in the Report
  9.2.1 Drug Delivery Devices
9.3 Secondary Research
9.4 Primary Research
9.5 Models
9.6 Forecasts
9.7 Expert Panel Validation
9.8 Currency Conversion
9.9 Contact Us
9.10 Disclaimer 85

LIST OF TABLES

Table 1: Drug Delivery Devices, Egypt, Overall Revenue ($m), 2003-2017
Table 2: Drug Delivery Devices, Egypt, Overall Revenue ($m), Historic, 2003-2010
Table 3: Drug Delivery Devices, Egypt, Overall Revenue ($m), Forecast, 2010-2017
Table 4: Drug Delivery Devices, Egypt, Category Volume (Units), 2003-2017
Table 5: Drug Delivery Devices, Egypt, Category Volume (Units), Historic, 2003-2010
Table 6: Drug Delivery Devices, Egypt, Category Volume (Units), Forecast, 2010-2017
Table 7: Drug Delivery Devices, Egypt, Company Share by Revenue ($m), 2009-2010
Table 8: Central Venous Catheters, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Table 9: Central Venous Catheters, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Table 10: Central Venous Catheters, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Table 11: Central Venous Catheters, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Table 12: Central Venous Catheters, Egypt, Average Price ($), Historic, 2003-2010
Table 13: Central Venous Catheters, Egypt, Average Price ($), Forecast, 2010-2017
Table 14: Central Venous Catheters, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 15: Central Venous Catheters, Egypt, Company Share by Revenue ($m), 2009-2010
Table 16: Infusion Systems, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Table 17: Infusion Systems, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Table 18: Syringe Pumps, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 19: Syringe Pumps, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 20: Ambulatory Infusion Pumps, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 21: Ambulatory Infusion Pumps, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 22: Infusion Systems, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Table 23: Infusion Systems, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Table 24: Syringe Pumps, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 25: Syringe Pumps, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 26: Ambulatory Infusion Pumps, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 27: Ambulatory Infusion Pumps, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 28: Infusion Systems, Egypt, Average Price ($), Historic, 2003-2010
Table 29: Infusion Systems, Egypt, Average Price ($), Forecast, 2010-2017
Table 30: Infusion Systems, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 31: Infusion Systems, Egypt, Company Share by Revenue ($m), 2009-2010
Table 32: Metered Dose Inhaler Devices, Egypt, Revenue ($m), Historic, 2003-2010
Table 33: Metered Dose Inhaler Devices, Egypt, Revenue ($m), Forecast, 2010-2017
Table 34: Metered Dose Inhaler Devices, Egypt, Volume (Units), Historic, 2003-2010
Table 35: Metered Dose Inhaler Devices, Egypt, Volume (Units), Forecast, 2010-2017
Table 36: Metered Dose Inhaler Devices, Egypt, Average Price ($), Historic, 2003-2010
Table 37: Metered Dose Inhaler Devices, Egypt, Average Price ($), Forecast, 2010-2017
Table 38: Metered Dose Inhaler Devices, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 39: Metered Dose Inhaler Devices, Egypt, Company Share by Revenue ($m), 2009-2010
Table 40: Needle Free Injections, Egypt, Revenue ($m), Historic, 2003-2010
Table 41: Needle Free Injections, Egypt, Revenue ($m), Forecast, 2010-2017
Table 42: Needle Free Injections, Egypt, Volume (Units), Historic, 2003-2010
Table 43: Needle Free Injections, Egypt, Volume (Units), Forecast, 2010-2017
Table 44: Needle Free Injections, Egypt, Average Price ($), Historic, 2003-2010
Table 45: Needle Free Injections, Egypt, Average Price ($), Forecast, 2010-2017
Table 46: Needle Free Injections, Egypt, Distribution Share by Revenue ($m), 2009-2010
Table 47: Needle Free Injections, Egypt, Company Share by Revenue ($m), 2009-2010
Table 48: USD to Local Currency, Egypt, Average Actual Rate 2003-2010 84

LIST OF FIGURES

Figure 1: Drug Delivery Devices, Egypt, Overall Revenue ($m), 2003-2017
Figure 2: Drug Delivery Devices, Egypt, Overall Revenue ($m), Historic, 2003-2010
Figure 3: Drug Delivery Devices, Egypt, Overall Revenue ($m), Forecast, 2010-2017
Figure 4: Drug Delivery Devices, Egypt, Category Volume (Units), 2003-2017
Figure 5: Drug Delivery Devices, Egypt, Category Volume (Units), Historic, 2003-2010
Figure 6: Drug Delivery Devices, Egypt, Category Volume (Units), Forecast, 2010-2017
Figure 7: Drug Delivery Devices, Egypt, Company Share (%), 2010
Figure 8: Central Venous Catheters, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Figure 9: Central Venous Catheters, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 10: Central Venous Catheters, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Figure 11: Central Venous Catheters, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Figure 12: Central Venous Catheters, Egypt, Company Share (%), 2010
Figure 13: Infusion Systems, Egypt, Revenue ($m) by Segment, Historic, 2003-2010
Figure 14: Infusion Systems, Egypt, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 15: Syringe Pumps, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 16: Syringe Pumps, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 17: Ambulatory Infusion Pumps, Egypt, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 18: Ambulatory Infusion Pumps, Egypt, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 19: Infusion Systems, Egypt, Volume (Units) by Segment, Historic, 2003-2010
Figure 20: Infusion Systems, Egypt, Volume (Units) by Segment, Forecast, 2010-2017
Figure 21: Syringe Pumps, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 22: Syringe Pumps, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 23: Ambulatory Infusion Pumps, Egypt, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 24: Ambulatory Infusion Pumps, Egypt, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 25: Infusion Systems, Egypt, Company Share (%), 2010
Figure 26: Metered Dose Inhaler Devices, Egypt, Revenue ($m), Historic, 2003-2010
Figure 27: Metered Dose Inhaler Devices, Egypt, Revenue ($m), Forecast, 2010-2017
Figure 28: Metered Dose Inhaler Devices, Egypt, Volume (Units), Historic, 2003-2010
Figure 29: Metered Dose Inhaler Devices, Egypt, Volume (Units), Forecast, 2010-2017
Figure 30: Metered Dose Inhaler Devices, Egypt, Company Share (%), 2010
Figure 31: Needle Free Injections, Egypt, Revenue ($m), Historic, 2003-2010
Figure 32: Needle Free Injections, Egypt, Revenue ($m), Forecast, 2010-2017
Figure 33: Needle Free Injections, Egypt, Volume (Units), Historic, 2003-2010
Figure 34: Needle Free Injections, Egypt, Volume (Units), Forecast, 2010-2017
Figure 35: Needle Free Injections, Egypt, Company Share (%), 2010
Figure 36: Global Markets Direct Methodology 79

COMPANIES MENTIONED
GlaxoSmithKline plc
AstraZeneca PLC
Boehringer Ingelheim GmbH
B. Braun Melsungen AG
Fresenius Kabi AG
Hospira, Inc.
Medtronic, Inc.
Baxter International Inc.
Smiths Medical
Terumo Corporation
3M Health Care
CareFusion Corporation
Teleflex Incorporated
Arcomed A.G. Medical Systems
Edwards Lifesciences Corporation
JMS CO., LTD.
Cook Medical Incorporated
Consort Medical plc
Becton, Dickinson and Company
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.

Ask Your Question

Egypt Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: